Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Pilavapadin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase
    Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase

    22 Jan 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/lexicon-opens-path-to-1b-opportunity-as-fda-greenlights-phase-iii-for-non-opioid-pill

    BIOSPACE
    22 Jan 2026
    Share Share
    Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain
    Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3222788/0/en/Lexicon-Pharmaceuticals-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-For-Pilavapadin-in-the-Treatment-of-Diabetic-Peripheral-Neuropathic-Pain.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Lexicon Presents Pilavapadin Data in Peripheral Neuropathy
    Lexicon Presents Pilavapadin Data in Peripheral Neuropathy

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166098/0/en/Lexicon-Pharmaceuticals-Presents-Additional-Pilavapadin-Data-in-Diabetic-Peripheral-Neuropathic-Pain-at-19th-Annual-Pain-Therapeutics-Summit.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med
    Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med

    18 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/lexicon-backs-phase-iii-go-decision-for-non-opioid-pain-med-with-post-hoc-analysis

    BIOSPACE
    18 Sep 2025
    Share Share
    Pilavapadin Shows Significant Pain Relief in Adults
    Pilavapadin Shows Significant Pain Relief in Adults

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151499/0/en/Pilavapadin-Provides-Meaningful-Pain-Reduction-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain-DPNP-in-Data-Presented-at-the-European-Association-for-the-Study-of-Diabetes-EASD.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    Lexicon Pharma to Share More Pilavapadin Clinical Data at Meeting
    Lexicon Pharma to Share More Pilavapadin Clinical Data at Meeting

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148532/0/en/Lexicon-Pharmaceuticals-to-Present-Additional-Clinical-Data-on-Pilavapadin-at-Three-Upcoming-Medical-Meetings.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.